Please assess the completion status of the following clinical trial:

Trial Title: Feeding Study in VLBW Premature Infants

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Clinically and metabolically stable~* Birth weight 700 g to less than or equal to 1,250 g~* Appropriate birth weight for gestational age~* 24 0/7 to 32 0/7 weeks' gestational age at birth~* Exclusively fed human milk~* Signed informed consent and authorization to use and/or disclose PHI~Exclusion Criteria:~* Metabolic or chronic disease~* 5-minute Apgar score \<4~* Major surgery~* Ventilator dependent~* Fluid restriction~* Grade III or IV intraventricular hemorrhage (IVH)

- Gender: ALL
- Minimum Age: 168 Days
- Maximum Age: 224 Days
- Healthy Volunteers: f

Study Arms:
- Commercial Liquid Human Milk Fortifier (Type: ACTIVE_COMPARATOR): Liquid human milk fortifier to be added to human milk
- Liquid Human Milk Fortifier - Standard Protein (Type: EXPERIMENTAL): Liquid human milk fortifier to be added to human milk
- Liquid Human Milk Fortifier - High Protein (Type: EXPERIMENTAL): Liquid human milk fortifier to be added to human milk

Based on this trial design, predict the completion outcome and termination type (if applicable).